21.6.2018 | Ajankohtaista
Geneticists – Blueprint Genetics, Helsinki FI
Job description
Introduction
Blueprint Genetics is on a mission to bring world-class genetic knowledge to mainstream healthcare. To meet the challenges imposed by our rapid growth, we are looking for new Geneticists to join our Clinical Interpretation Team. We are a team of experienced professionals with diverse backgrounds who share the passion for helping patients and families suffering from inherited disorders. Our constantly evolving diagnostic portfolio currently includes over 200 tests that cover a wide variety of clinical specialties and diagnostic approaches, including Whole Exome Sequencing. We work with hundreds of clinics around the globe and the quality of our interpretation has been praised by many of the world’s best medical centers. If you have the ambition to be among the pioneers of the molecular era of medicine, you might be the person we are looking for.
Job Description
The position involves interpretation and reporting of findings from our clinical molecular genetic tests, including panel-based tests, targeted family member tests and others. Our Geneticists also participate in the development and validation of products and applications in a project team environment. Those interested get to collaborate with our Software Engineers and Data Scientists with the development of our proprietary software tools that enable us to interpret identified variants efficiently by utilizing artificial intelligence and machine learning.
Education
Qualifications
-
- Clinical Laboratory Geneticist degree; or
- Board certification in Clinical Molecular Genetics / Laboratory Genetics and Genomics; or
- Ph.D. in Genetics.
Experience And Skills
-
- Experience in interpreting and reporting genetic test results in a clinical setting utilizing NGS, Sanger sequencing and other methods is an asset, but similar research experience is valued as well.
- Knowledge of current genomic information and variant databases is essential.
- Experience in working under certified and accredited quality management systems is an asset.
- Fluent skills in oral and written English are a necessity.
Personal Attributes
-
- Great attention to detail
- Critical thinking when reviewing scientific literature
- Effective planning and organization skills
- Excellent follow-through abilities
- Fitting the immediate, low-hierarchy and positive Blueprint culture
What We Offer
At Blueprint Genetics, you get to be a valued part of our global and multidisciplinary team of people who want to make a difference. You will be working daily to bring your expertise from base pairs to bedside for improved patient outcomes. We offer you a rapidly evolving working environment where you can learn and grow together with a unique company and great colleagues. You get to use everything you have learned in an environment that is unlike anything you have experienced before.
Apply at the latest by 2nd of July
Inquiries about the position can be sent to Clinical Interpretation Team Leader Dr. Eveliina Salminen at eveliina.salminen[at]blueprintgenetics.com
20.6.2018 | Ajankohtaista
Multiple Postdoctoral Fellow Positions in Epigenetics, human iPS cells, Hematopoietic Stem Cell Biology, Bioengineering, and Blood Cancers: Columbus, OH, United States
Multiple postdoctoral fellow positions are available in the Dhvanit Shah Laboratory (www.shahlaboratory.org) at the Center for Childhood Cancers and Blood Diseases, Nationwide Children’s Hospital & Ohio State University, Columbus OH, United States.
The Shah laboratory provides a dynamic microenvironment that offers excellent opportunities for intellectual exchange and collaborations among investigators from diverse fields. We investigate the origin, development, and differentiation of hematopoietic stem cells (HSCs), and their utility in treating patients with blood and bone-marrow diseases. We have expertise in utilizing zebrafish, mice, and human induced pluripotent stem (iPS) cells to analyze novel genes and mechanisms important for blood formation. Our goals are to utilize our knowledge in developing cellular- and mechanism-based therapies as well as generating functional HSCs for the treatment of hematological diseases.
Position # 1: Epigenetics of Hematopoietic Stem Cell Development and Disorders
The ideal candidate will have Ph.D., M.D., or M.D./Ph.D. in Regenerative Medicine, Stem Cells, Immunotherapy, Hematology, Oncology, and/or Biology. This position offers an excellent opportunity to learn and apply skills in epigenetics, directed differentiation of human induced pluripotent stem cells (iPSCs), HSC transplant, xenograft, computational biology, high-throughput screening, gene-editing, and/or molecular and cellular biology techniques.
Position # 2: Bioengineering of 3D Scaffold Development
The ideal candidate will have Ph.D., M.D., or M.D./Ph.D. in Tissue Engineering, Biomaterials, Biophysics, Machine Learning, Systems Biology, Chemical Engineering, and/or Drug Development. This position offers an excellent opportunity to learn and apply skills in organoid development, 3D bio-printing, Bio-MEMS, artificial intelligence, microfluidics, proteomics, and/or medicinal chemistry.
Strong background in one or more of these areas is preferred but not required. Qualified candidate should be able to work independently as well as in a group environment.
Interested candidates should send their cover letter, CV, and contact details of three references to:
Center for Childhood Cancers,
Nationwide Children’s Hospital &
Ohio State University College of Medicine
700 Children’s Drive, WA 5015
NCH & OSU are an affirmative action/equal opportunity employers.
19.6.2018 | Ajankohtaista
The Université de Sherbrooke and the Department of Pharmacology-Physiology is seeking applications to fulfil a Faculty position (Assistant Professor; Tenure-track) in Pharmacology of Cannabinoids.
The search committee will begin evaluating applications after July 1st. The position will remain open until a candidate has been hired.
19.6.2018 | Ajankohtaista
The Department of Anesthesiology and Washington University Pain Center seeks an Postdoctoral Research Fellow for an individual interested in examining the mechanisms underlying the intersection between opioid misuse and pain.
The laboratory integrates the study of the molecular and cellular changes induced by drugs of abuse and pain using a combination of state-of-art behavioral, optogenetics, chemogenetics approaches in combination with electrophysiological analyses. For more details see lab web page (http://elysium.wustl.edu/moron-concepcion_lab/)
Candidates must have a PhD in neuroscience, biochemistry, pharmacology or biomedical sciences. The successful candidate should be able to work independently and be willing to collaborate with the groups within the Pain Center at the Department of Anesthesiology.
Interested candidates should also forward their CV and names of 3 references to:
Jose A. Morón Concepción, PhD
Associate Professor
Depts of Anesthesiology & Neuroscience
Washington University School of Medicine
18.6.2018 | Ajankohtaista
The Fagerholm group at the Faculty of Bio- and Environmental Sciences, University of Helsinki is seeking to recruit a POSTDOCTORAL RESEARCHER
The position is available from 1st September 2018 for minimum of one year with the possibility of extension.
The postdoc will participate in an Academy of Finland-funded project which investigates the molecular mechanisms by which integrins regulate immune cell programming and immune cell-mediated tumor rejection.
The Fagerholm group consists of Immunologists and Biochemists working together to understand the molecular mechanisms which regulate immune cell trafficking and function in vivo. We are especially interested in the role of integrins in immune system regulation and in immune-system related diseases such as immunodeficiency and cancer. We use a wide range of techniques such as mouse genetics, tumor models, in vivo immune cell migration and other functional assays, flow cytometry, cell biology, imaging and next generation sequencing to understand the molecular mechanisms involved in the regulation of immune cell function.
Deadline for applications is 31.07.2018 23:59 EEST.
16.6.2018 | Ajankohtaista
Laboratory technician – Nightingale Health Oy, Helsinki
Are you passionate about healthcare and public health research? Do you want to work in a state of the art laboratory with cutting edge analytical technology?
Nightingale Health is looking for a laboratory technician to join our delivery team. Our delivery team serves global customers, using NMR spectroscopy to deliver analytical measurements for population health research and clinical use.
We’re looking for an enthusiastic and dependable laboratory technician with some prior knowledge of analytical measurements and work experience in a clinical laboratory. Previous experience of NMR spectroscopy or automated liquid handlers is not required but is considered an asset.
We are looking for people with:
– Trained laboratory technician or medical laboratory scientist (or equivalent) passionate about utilizing the latest measurement techniques, especially nuclear magnetic resonance (NMR) spectroscopy
– A ”quality first” mind-set
– Work experience with analytical measurements
– Willingness to adapt to a flexible team culture and learn novel measurement technologies
– Strong knowledge of the English language, Finnish is a plus but not mandatory
We offer:
– Responsibility and independence as a member of the delivery team
– Unique opportunity to work in a multidisciplinary team of scientists, developers and biotech business professionals
– Full-time position in our laboratory in Helsinki or Kuopio
– Attractive employment conditions and competitive salary
The position is available immediately or upon agreement.
How to apply?
If you are interested in joining our rapidly growing team, please send your application to people@nightingalehealth.com. The applications should include a cover letter and CV. The applications may be submitted in Finnish or in English.
16.6.2018 | Ajankohtaista
Sales Representative – SOPHiA GENETICS, Finlande
Job description
Ranked among the ”50 Smartest Companies” in the world according to the MIT Technology Review SOPHiA GENETICS is a fast-paced rapidly growing health tech company with a team of world renowned experts in the fields of technology (AI), life sciences (genomics) and information technology (data security) sectors.
SOPHiA GENETICS has developed SOPHiA™ Artificial Intelligence, the most advanced and used technology for clinical genomics. Deployed as a Software as a Service SOPHiA DDM® has connected over 425 world-leading hospitals and analyses thousands of patients’ genomics profiles each month to better and faster diagnose them.
In our mission to democratize Data-Driven Medicine, we are looking for bright, passionate and dedicated individuals to join our growing dynamic team. Does this sound like you? If so, we want to hear from you…
Sales & Business Development Manager
As part of the sales team, you will be in charge to acquire new accounts as well as managing existing ones within your territory (Finland, Estonia, Latvia, Lithuania) for our portfolio. This position requires to intensely travel across your territory as well as in Switzerland twice per year where is based our headquarter.
You will have to be creative and find solutions in order to meet clients. You will be supported by a well-resourced team of technical specialists and will leverage on our network within the clinical diagnostic testing field. The ability to develop long-term relationships with clients and communicate your enthusiasm for the potential of use of our solution transition to data-driven personalized medicine is essential. Our teams will support you in achieving ambitious goals in terms of acquisition of new clients and sales by sharing with you best practices. If you are client oriented and a result person you might probably join our team.
Qualifications and Experience
- A master degree in Sciences within a well-regarded institution; PhD will be an advantage.
- Excellent communication skills, including experience in communicating complex scientific principles in simple terms.
- Finnish and English (the business language) is mandatory.
- Ideally, previous experience as working as part of a team to develop the company’s customer base and provide a first-class experience to clients, preferably in the clinical diagnostics, biotechnology or medical technology market.
Starting date: ASAP
Location: Home office
If you think you fit this position, please send a CV and a cover letter.
Please note that incomplete applications will not be considered.
16.6.2018 | Ajankohtaista
Clinical Research Associate / Study Manager – PerkinElmer, Inc. Turku, VARS
Job description
PerkinElmer is currently looking for
Clinical Research Associate / Study Manager
Turku, Finland / Diagnostics
The Turku Site, with 550 employees, represents one of PerkinElmer’s major manufacturing and product development sites for newborn- and maternal fetal health screening. As the global market leader in newborn screening, our solutions have tested over 560 million babies worldwide for life-threatening diseases.
Medical and Scientific Affairs organization is responsible for clinical validation of our products. We now are looking for a new colleague to our global MSA team. The position may also be located in Sollentuna where PerkinElmer has a center of excellence for research and development of molecular diagnostic products.
Role description:
-
- Plan, execute and report studies according to applicable regulatory requirements and company SOPs
-
- Prepare study protocols and start-up activities at study sites
-
- Obtain ethical and regulatory approvals
-
- Monitor studies and report results
-
- Coordinate studies and develop internal clinical study management procedures
-
- Work in close collaboration with different functions and stakeholders including R&D, Regulatory and Business
Role requirements:
-
- M.Sc or equivalent in bioscience
-
- Experience in clinical studies, preferably related to In Vitro Diagnostic or Medical Device products
-
- Excellent organizational and communication skills
-
- Ability to work independently
-
- Proven ability to work in global team environment
-
- Fluent Finnish or Swedish and English (spoken and written)
-
- Ability to travel up to 30 days per year, mainly in Europe
-
- Depending on your previous experience with IVD clinical studies the position may be either Clinical Research Associate or Clinical Study Manager.
What we offer:
-
- Opportunity to work in a global team
-
- Dynamic and innovative culture
-
- Focus on career development
-
- Collaborative and diverse environment
In this position, you will be reporting to the Leader of Global Clinical Affairs, Turku. The position is temporary, approximately for 1 year, and can be located in Turku, Finland or Sollentuna, Sweden.
This position provides an exciting opportunity to work in a highly international business environment. If you are interested in the position and feel that you have the necessary skills and experience, please fill your application by June 25th, 2018. We will review the applications on an ongoing basis.
The PerkinElmer Turku Site is a drug free site and a medical examination for new employees includes a drug test.
16.6.2018 | Ajankohtaista
Solubiologi 1/2018 lehden pääkirjoitus sekä artikkeleiden abstraktit löytyvät nyt nettisivuiltamme! Muistathan, että yhdistyksen jäsenillämme on mahdollisuus lukea uusin Solubiologi-lehti myös jäsenintrassamme pdf-muodossa. Intrasta löytyy lehden lisäksi myös muunmuassa lista yhdyshenkilöistämme, joihin jäsenemme voivat olla yhteydessä esimerkiksi gradu- tai harjoittelupaikan tiimoilta. Tarkista tunnuksesi jäsenintraan viimeisimmästä jäsenkirjeestä!

16.6.2018 | Ajankohtaista
Pääkirjoitus, 28.05.2018
Suomen kesä on alkanut erittäin lämpimästi ja kesän tuloon liittyy tietysti myös vuoden ensimmäinen Solubiologi. Tämän vuotisen kevään numeron aloittaa Marjaana Parikainen, joka avartaa meille kollageeni I:stä sitovan α2β1-integriinin roolia eturauhassyövässä, ja tämän vaikutusta geeniekspressioon ja invaasioon. Seuraavaksi Teemu Syrjälä kertoo meille brominoituneista palonestoaineista ja niiden vaikutuksista syöttösoluihin. Tämänkertaisen tietopaketin päättää Moona Huttusen ulkomaankirjeenvaihtotervehdys, jossa käydään läpi hänen jo kolme vuotta kestäneitä seikkailuitaan Lontoossa University Collegessa, Englannissa.
Tänä kesänä saimme mahdollisuuden lähteä laboratorioryhmän kanssa joukolla Suomea pakoon vierailulle TuE:hen (Technische Universiteit Eindhoven) Eindhoveniin, Hollantiin, jossa tapasimme ryhmänjohtajamme Cecilia Sahlgrenin toisen ryhmän tiimiläisiä. Ahkerana professorina Cecilia pyörittää siis kahta kokonaisuutta, ja olihan se mielenkiintoista päästä tutustumaan teknillisen yliopiston työtapoihin ja tekniikkoihin. Tämä alunperin 1956 perustettu yliopisto kouluttaa pääasiassa insinöörejä teknologian alalla, mutta solu- ja kudostekniikan ja mikrofabrikoinnin laboratoriot yhdistävät solubiologiaa ja biotekniikkaa. Yhteistyö insinöörien ja solubiologien välillä on tärkeässä asemassa TuE:ssa, kun kehitetään esimerkiksi keinotekoisia sydänläppiä tai mikrosiruja, joilla halutaan simuloida erilaisia olosuhteita, joihin solut voivat joutua. Lopullisena päämääränä on kehittää niin sanottuja organ-on-a-chip –menetelmiä, joilla voitaisiin simuloida kokonaisia elimiä pienoismallissa.
Tämä jäänee omalta osaltani päätoimittajuuteni viimeiseksi Solubiologi-lehdeksi, koska syksyllä puikkoihin tarttuu J.J. Hyvää kesän jatkoa kaikille toivottaa SEb ja koko Solubiologin väki.
– Sebastian Landor
”I am the easy-going doctor who does not need to salute properly. You will find that I am always removing my gloves. The reason for my lab coat being a slightly different color to yours is never explained.”
1. Artikkeli. Kollageenireseptori α2-integriini säätelee eturauhassyöpäsolujen geeniekspressiota ja invaasiota, Marjaana Parikainen (FM)
Erikoistyössä tutkittiin α2-integriinin vaikutusta eturauhassyöpäsolujen geeniekspressioon sekä solujen migraatioon ja invaasioon neljällä α2-integriiniä erilaisesti ilmentävällä DU145-solutyypillä. α2-integriinin havaittiin säätelevän tiettyjen geenien ilmentymistä sekä RNA- että proteiinitasolla mutta se ei vaikuttanut säätelemiensä proteiinien lokalisaatioon solussa. Lisäksi havaittiin, että α2β1-kollageeni I -vuorovaikutus lisäsi solutyyppien välisiä RNA-tason ilmentymiseroja suurimmalla osalla tutkituista 12 geenistä, minkä perusteella α2-integriinin aktivoituminen ja signalointi ligandivuorovaikutuksessa säätelee näiden geenien ilmentymistä. α2-integriiniä ilmentävät solut invasoivat enemmän Matrigeeliin ja kollageeni I:een kuin α2-integriiniä ilmentämättömät solut. Tulosten perusteella α2β1-integriiniin kohdentuvaa syöpähoitoa voitaisiin mahdollisesti hyödyntää eturauhassyövän luumetastaasien estämiseen.
2. Artikkeli. The effects of some common brominated flame retardants (bfrs) on cell degranulation and cell viability in a mast cell line, Teemu Syrjälä (Biomedical Laboratory Scientist, Bachelor of Health Care; EQF6)
The aim of this study was to investigate the effects of two commonly used brominated flame retardants, tetrabromobisphenol A (TBBPA) and hexabromocyclododecane (HBCD), on degranulation and viability of a mast cell line RBL-2H3. Assays measuring and monitoring cell viability and the release of inflammatory proteins via degranulation were developed. The results showed that both TBBPA and HBCD cause substantial cell death over a long-term exposure in vitro. Both compounds caused some degranulation of the cells, although the results from HBCD turned out to be quite modest compared to those gotten from TBBPA. TBBPA greatly induced cell death by apoptosis while only a very small degree of necrotic cell death was observed. While the degree of necrosis caused by HBCD remains unknown, it was shown to also induce apoptotic cell death at least to some extent. The study concludes that TBBPA, based on the results, does seem to be a mast cell sensitizing agent. HBCD has great potential to have similar effects, although this requires further research.
3. Artikkeli. Ulkomaankirjeenvaihtaja, London University College (UCL) Englanti, Moona Huttunen (FT)



